Clene Inc (CLNN)
0.3772
-0.01
(-2.18%)
USD |
NASDAQ |
May 17, 16:00
0.3772
0.00 (0.00%)
After-Hours: 20:00
Clene Gross Profit Margin (Quarterly): 78.08% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 78.08% |
| December 31, 2023 | 77.65% |
| September 30, 2023 | 88.89% |
| June 30, 2023 | 75.46% |
| March 31, 2023 | 95.33% |
| December 31, 2022 | 97.01% |
| September 30, 2022 | 89.08% |
| June 30, 2022 | |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | 87.27% |
| June 30, 2021 | -176.1% |
| March 31, 2021 | -14.08% |
| December 31, 2020 | 75.86% |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 17.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-176.1%
Minimum
Jun 2021
97.01%
Maximum
Dec 2022
49.30%
Average
77.86%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 68.19% |
| Protalix BioTherapeutics Inc | 30.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -413.9% |
| Return on Assets | -91.90% |
| Return on Invested Capital | -127.7% |
| Profit Margin (Quarterly) | -15.18K% |
| Operating Margin (Quarterly) | -11.91K% |
| Return on Net Operating Assets | -276.4% |